Home / Grants / Grant

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Updated

Cooperative agreement from the National Institutes of Health, open to small businesses. Closes Nov 5, 2027, 381 days left.

Be among the first to see new federal grants for small businesses
Only new grants that match, once a day. $29 a month or $290 a year, cancel any time.
Opportunity numberPAR-25-297
AgencyNational Institutes of Health
Funding typeCooperative agreement
FieldHealth
Award ceiling$1.5 million
Cost sharing or matchingNot required
Assistance listing93.866
PostedDec 4, 2024
ClosesNov 5, 2027 (381 days left)
Add the deadline toGoogle Calendar

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Description

The goal of this Notice of Funding Opportunity (NOFO) is to provide funding support for the pre-clinical and early stage clinical (Phase I) development of novel small-molecule and biologic drug candidates that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as medicinal chemistry; pharmacokinetics (PK); Absorption, Distribution, Metabolism, Excretion, Toxicology (ADMET); efficacy in animal models; development of biomarkers for target engagement; formulation development; chemical synthesis under Good Manufacturing Practices (GMP); Investigational New Drug (IND) enabling studies; and initial Phase I clinical testing.

Applications not responsive to this NOFO include research on basic mechanisms of disease or mechanisms of drug action; development ofrisk, diagnostic, prognostic, predictive, and preventionbiomarkers, devices, non-pharmacological interventions (e.g., exercise, diet, cognitive training), repurposed drugs and combination therapies; discovery activities such as high-throughput screening and hit optimization; and stand-alone clinical trials.

Full announcement and how to apply on Grants.gov

Health grants right now

There are 350 open federal grants in health that small businesses may apply for; 33 close within 30 days. The median award ceiling is $500,000; this grant offers up to $1.5 million. The agencies offering the most are National Institutes of Health, Centers for Disease Control and Prevention - ERA and Centers for Disease Control - NCBDDD. Grants in this field stay open a median of 1031 days; this one is open for 1066 days.

Who has won this program before

The largest grants and cooperative agreements under assistance listing 93.866 with funding activity since Oct 1, 2025, from USAspending.gov. Amounts are each award's total.

Other open grants in the same program

Under assistance listing 93.866, the federal program this grant is paid from.

HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Grant · PAR-27-045
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Closes Nov 6, 2026 · 17 days left
Grant · Up to $350,000 an award · PAR-25-095
Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
National Institutes of Health
Closes Nov 10, 2026 · 21 days left
Cooperative agreement · RFA-AG-27-010
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Closes Nov 17, 2026 · 28 days left
Grant · Up to $200,000 an award · PAR-25-096
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
National Institutes of Health
Closes Nov 24, 2026 · 35 days left
Grant · PA-23-317

More open grants from the National Institutes of Health

340 open grants from this agency accept small businesses, with $356.4 million in total program funding listed.

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
National Institutes of Health
Closes Oct 20, 2026 · today
Grant · Up to $750,000 an award · RFA-DK-27-120
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
National Institutes of Health
Closes Oct 22, 2026 · 2 days left
Grant · RFA-MH-27-140
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $1.2 million an award · RFA-HG-27-011
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $500,000 an award · RFA-HG-27-013
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Closes Oct 30, 2026 · 10 days left
Cooperative agreement · Up to $2.2 million an award · RFA-HG-27-012

All open federal grants for small businesses